NO20063495L - Kjemokine CCR5-receptormodulatorer - Google Patents
Kjemokine CCR5-receptormodulatorerInfo
- Publication number
- NO20063495L NO20063495L NO20063495A NO20063495A NO20063495L NO 20063495 L NO20063495 L NO 20063495L NO 20063495 A NO20063495 A NO 20063495A NO 20063495 A NO20063495 A NO 20063495A NO 20063495 L NO20063495 L NO 20063495L
- Authority
- NO
- Norway
- Prior art keywords
- derivatives
- present
- disorders
- receptor modulators
- diaza
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4747—Quinolines; Isoquinolines spiro-condensed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/537—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines spiro-condensed or forming part of bridged ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- AIDS & HIV (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Foreliggende oppfinnelse omhandler piperidinderivater med formel (1) med substituenter som definert her som er anvendelige ved behandlingen av en rekke lidelser, inkludert de hvor moduleringen av CCR5 reseptorer er implisert. Mer spesielt omhandler foreliggende oppfinnelse 1 -oksa-3,8-diaza-spiro[4.5]dekan-2-on og 1 -oksa-3,9-diaza-spiro[5.5]undekan-2-on forbindelser og relaterte derivater, preparater inneholdende dem og anvendelser av slike derivater. Lidelser som kan behandles eller forhindres ved foreliggende derivater inkluderer HIV og genetisk relaterte retrovirale infeksjoner (og den resulterende ervervet immunsvikt syndrom, AIDS), sykdommer i immunsystemet og inflammatoriske sykdommer.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US54340804P | 2004-02-10 | 2004-02-10 | |
PCT/EP2005/000976 WO2005075484A2 (en) | 2004-02-10 | 2005-02-01 | Chemokine ccr5 receptor modulators |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20063495L true NO20063495L (no) | 2006-11-01 |
Family
ID=34837578
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20063495A NO20063495L (no) | 2004-02-10 | 2006-07-31 | Kjemokine CCR5-receptormodulatorer |
Country Status (15)
Country | Link |
---|---|
US (2) | US7332500B2 (no) |
EP (1) | EP1716156A2 (no) |
JP (1) | JP2007522160A (no) |
KR (1) | KR100863854B1 (no) |
CN (1) | CN100497346C (no) |
AR (1) | AR047536A1 (no) |
AU (1) | AU2005211499A1 (no) |
BR (1) | BRPI0507586A (no) |
CA (1) | CA2554671A1 (no) |
CO (1) | CO5700742A2 (no) |
IL (1) | IL176720A0 (no) |
NO (1) | NO20063495L (no) |
RU (1) | RU2006132465A (no) |
TW (1) | TW200529857A (no) |
WO (1) | WO2005075484A2 (no) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6374762B1 (en) * | 1997-10-27 | 2002-04-23 | Correct Craft, Inc. | Water sport towing apparatus |
US7879834B2 (en) * | 2004-08-19 | 2011-02-01 | Vertex Pharmaceuticals Incorporated | Spiroindoline modulators of muscarinic receptors |
US7786141B2 (en) * | 2004-08-19 | 2010-08-31 | Vertex Pharmaceuticals Incorporated | Dihydrospiroindene modulators of muscarinic receptors |
EP1817036B1 (en) * | 2004-11-29 | 2012-07-04 | Vertex Pharmaceuticals Incorporated | Modulators of muscarinic receptors |
CA2598530C (en) * | 2005-03-03 | 2014-12-16 | Janssen Pharmaceutica N.V. | Substituted oxa-diaza-spiro-[5.5]-undecanone derivatives and their use as neurokinin antagonists |
NZ556628A (en) | 2005-03-08 | 2009-09-25 | Janssen Pharmaceutica Nv | Diaza-spiro-[4.4]-nonane derivatives as neurokinin (NK1) antagonists |
CN101291905A (zh) | 2005-10-19 | 2008-10-22 | 弗·哈夫曼-拉罗切有限公司 | 苯乙酰胺nnrt抑制剂 |
EP1973543A2 (en) * | 2005-12-22 | 2008-10-01 | Vertex Pharmaceuticals Incorporated | Modulators of muscarinic receptors |
EP1988892A2 (en) * | 2006-02-22 | 2008-11-12 | Vertex Pharmaceuticals Incorporated | Modulators of muscarinic receptors |
US8263605B2 (en) * | 2006-02-22 | 2012-09-11 | Vertex Pharmaceutical Incorporated | Modulators of muscarinic receptors |
CA2656183A1 (en) * | 2006-06-29 | 2008-01-10 | Vertex Pharmaceuticals Incorporated | Modulators of muscarinic receptors |
CN101553231A (zh) * | 2006-08-15 | 2009-10-07 | 弗特克斯药品有限公司 | 毒蕈碱受体调节剂 |
DE602007013573D1 (de) | 2006-08-16 | 2011-05-12 | Hoffmann La Roche | Nicht-nukleosidische reverse-transkriptase-hemmer |
AU2007284350A1 (en) | 2006-08-18 | 2008-02-21 | Vertex Pharmaceuticals Incorporated | Modulators of muscarinic receptors |
EP2089384B1 (en) | 2006-12-13 | 2015-08-05 | F. Hoffmann-La Roche AG | 2-(piperidin-4-yl)-4-phenoxy-or phenylamino-pyrimidine derivatives as non-nucleoside reverse transcriptase inhibitors |
US20100093777A1 (en) * | 2007-01-25 | 2010-04-15 | Takeda Pharmaceutical Company Limited | Spiro-ring compound |
CN101646679A (zh) * | 2007-03-29 | 2010-02-10 | 弗·哈夫曼-拉罗切有限公司 | 杂环抗病毒化合物 |
US7977358B2 (en) * | 2007-07-26 | 2011-07-12 | Hoffmann-La Roche Inc. | Pyrazol derivatives |
WO2009037168A1 (en) * | 2007-09-19 | 2009-03-26 | F. Hoffmann-La Roche Ag | Heterocyclic antiviral compounds |
CA2700724A1 (en) * | 2007-10-03 | 2009-04-09 | Vertex Pharmaceuticals Incorporated | Modulators of muscarinic receptors |
JP2011519888A (ja) * | 2008-05-09 | 2011-07-14 | エフ.ホフマン−ラ ロシュ アーゲー | 抗ウイルス性複素環式化合物 |
JP5908397B2 (ja) | 2009-06-09 | 2016-04-26 | デフィルス、インコーポレイテッドDefyrus, Inc. | 病原体感染を予防又は治療するためのインターフェロン投与 |
WO2012171863A1 (en) * | 2011-06-16 | 2012-12-20 | Boehringer Ingelheim International Gmbh | New selective ccr2 antagonists |
ES2619829T3 (es) | 2011-11-18 | 2017-06-27 | Heptares Therapeutics Limited | Agonistas del receptor muscarínico M1 |
GB201404922D0 (en) | 2014-03-19 | 2014-04-30 | Heptares Therapeutics Ltd | Pharmaceutical compounds |
PT3377500T (pt) * | 2015-11-16 | 2022-11-25 | Esteve Pharmaceuticals Sa | Compostos de oxadiazaspiro para o tratamento de abuso e adição a drogas |
GB201617454D0 (en) | 2016-10-14 | 2016-11-30 | Heptares Therapeutics Limited | Pharmaceutical compounds |
US10501483B2 (en) | 2017-10-24 | 2019-12-10 | Allergan, Inc. | Enamines and diastereo-selective reduction of enamines |
GB201810239D0 (en) | 2018-06-22 | 2018-08-08 | Heptares Therapeutics Ltd | Pharmaceutical compounds |
WO2020048826A1 (en) | 2018-09-03 | 2020-03-12 | Bayer Aktiengesellschaft | 5-substituted 1-oxa-3,9-diazaspiro[5.5]undecan-2-one compounds |
WO2020048828A1 (en) | 2018-09-03 | 2020-03-12 | Bayer Pharma Aktiengesellschaft | 5-heteroaryl-3,9-diazaspiro[5.5]undecane compounds |
WO2020048827A1 (en) | 2018-09-03 | 2020-03-12 | Bayer Aktiengesellschaft | 1, 3, 9-triazaspiro[5.5] undecan-2-one compounds |
GB201819960D0 (en) | 2018-12-07 | 2019-01-23 | Heptares Therapeutics Ltd | Pharmaceutical compounds |
GB202020191D0 (en) | 2020-12-18 | 2021-02-03 | Heptares Therapeutics Ltd | Pharmaceutical compounds |
US11629196B2 (en) | 2020-04-27 | 2023-04-18 | Incelldx, Inc. | Method of treating SARS-CoV-2-associated hypercytokinemia by administering a human monoclonal antibody (PRO-140) that inhibits CCR5/CCL5 binding interactions |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL127065C (no) * | 1964-04-22 | |||
HU204529B (en) * | 1989-08-10 | 1992-01-28 | Richter Gedeon Vegyeszet | Process for producing new 1-oxa-2-oxo-8-aza-spiro(4,5)decane derivatives and pharmaceutical compositions containing them |
ATE274499T1 (de) | 1995-09-29 | 2004-09-15 | Lilly Co Eli | Spiro verbindungen als inhibitoren der fibrinogen-abhängigen blutplättchen aggregation |
US6391865B1 (en) * | 1999-05-04 | 2002-05-21 | Schering Corporation | Piperazine derivatives useful as CCR5 antagonists |
SK286641B6 (sk) * | 1999-05-04 | 2009-03-05 | Schering Corporation | Piperazínové deriváty užitočné ako CCR5 antagonisty, farmaceutické prípravky s ich obsahom a ich použitie |
SK286968B6 (sk) | 1999-05-04 | 2009-08-06 | Schering Corporation | Piperidín-piperidinyl ako CCR5 antagonista, farmaceutický prostriedok s jeho obsahom a jeho použitie |
US6689765B2 (en) * | 1999-05-04 | 2004-02-10 | Schering Corporation | Piperazine derivatives useful as CCR5 antagonists |
WO2001040227A1 (fr) | 1999-12-03 | 2001-06-07 | Ono Pharmaceutical Co., Ltd. | Derives triazaspiro[5.5]undecane et medicaments contenant ces derives en tant que principe actif |
WO2001057044A1 (fr) | 2000-02-01 | 2001-08-09 | Daiichi Pharmaceutical Co., Ltd. | Derives de pyrido-oxazine |
AU2001243394A1 (en) * | 2000-03-02 | 2001-09-12 | Smith Kline Beecham Corporation | Compounds and methods |
PT1390372E (pt) * | 2001-05-14 | 2008-08-25 | Hoffmann La Roche | Derivados de 1-oxa-3, 9-diaza-espiro(5, 5) undecan-2-onas e a sua utilização a título de antagonistas do receptor de neuriquinina |
NZ571695A (en) | 2001-12-28 | 2010-02-26 | Acadia Pharm Inc | Spiroazacyclic compounds as monoamine receptor for modulating 5-HT2A receptor-mediated events |
-
2005
- 2005-02-01 CN CNB2005800045181A patent/CN100497346C/zh not_active Expired - Fee Related
- 2005-02-01 AU AU2005211499A patent/AU2005211499A1/en not_active Abandoned
- 2005-02-01 JP JP2006552503A patent/JP2007522160A/ja active Pending
- 2005-02-01 CA CA002554671A patent/CA2554671A1/en not_active Abandoned
- 2005-02-01 KR KR1020067016037A patent/KR100863854B1/ko not_active IP Right Cessation
- 2005-02-01 EP EP05707116A patent/EP1716156A2/en not_active Withdrawn
- 2005-02-01 BR BRPI0507586-6A patent/BRPI0507586A/pt not_active IP Right Cessation
- 2005-02-01 RU RU2006132465/04A patent/RU2006132465A/ru not_active Application Discontinuation
- 2005-02-01 WO PCT/EP2005/000976 patent/WO2005075484A2/en active Application Filing
- 2005-02-05 TW TW094103869A patent/TW200529857A/zh unknown
- 2005-02-08 AR ARP050100437A patent/AR047536A1/es unknown
- 2005-02-10 US US11/055,642 patent/US7332500B2/en not_active Expired - Fee Related
-
2006
- 2006-07-05 IL IL176720A patent/IL176720A0/en unknown
- 2006-07-31 CO CO06074877A patent/CO5700742A2/es not_active Application Discontinuation
- 2006-07-31 NO NO20063495A patent/NO20063495L/no not_active Application Discontinuation
-
2008
- 2008-01-11 US US12/008,452 patent/US7538122B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
IL176720A0 (en) | 2006-10-31 |
KR20060108770A (ko) | 2006-10-18 |
CO5700742A2 (es) | 2006-11-30 |
BRPI0507586A (pt) | 2007-07-03 |
US20050176703A1 (en) | 2005-08-11 |
US20080139544A1 (en) | 2008-06-12 |
CN1918171A (zh) | 2007-02-21 |
AR047536A1 (es) | 2006-01-25 |
JP2007522160A (ja) | 2007-08-09 |
WO2005075484A3 (en) | 2005-10-20 |
TW200529857A (en) | 2005-09-16 |
WO2005075484A2 (en) | 2005-08-18 |
CN100497346C (zh) | 2009-06-10 |
AU2005211499A1 (en) | 2005-08-18 |
US7332500B2 (en) | 2008-02-19 |
KR100863854B1 (ko) | 2008-10-15 |
CA2554671A1 (en) | 2005-08-18 |
RU2006132465A (ru) | 2008-03-20 |
EP1716156A2 (en) | 2006-11-02 |
US7538122B2 (en) | 2009-05-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20063495L (no) | Kjemokine CCR5-receptormodulatorer | |
NO20070489L (no) | 3-aminocyklopentankarboksamider som modulatorer av kjemokinreseptorer. | |
NO331068B1 (no) | Benzazepinderivater for behandling av nevrologiske forstyrrelser. | |
NO20092342L (no) | Azaspiroderivativater | |
NO20061978L (no) | Imidazopyridinsubstituerte tropanderivater med CCR5-reseptorantagonist aktivitet for behandling av HIV og inflammasjon | |
NO20050635L (no) | Nye tricykliske spiropiperidiner eller spiropyrrolidiner | |
NO20061952L (no) | Pyrimidin-2-aminderivater og deres anvendelse som A2B-adenosinreseptorantagonister | |
NO20074258L (no) | Pyridin-2-karboksamidderivater som MGLUR5 antagonister | |
NO20060168L (no) | Pyridinylkarbamater som hormonsensitive lipaseinhibitorer | |
NO20063469L (no) | Polyeheterosykliske forbindelser og deres anvendelse som metabotrofe glutamat reseptorantagonister | |
NO20052739L (no) | CCR5-antagonister som medikamenter | |
NO20085176L (no) | Fenyl substituerte heteroaryl-derivater og andvendelse som anti-tumor agenter | |
NO20073140L (no) | Pyrrolopyraziner og pyralopyraziner som er nyttige som inhibitorer av proteinkinaser | |
NO20092050L (no) | Nye sulfonamidderivater som bradykininantagonister | |
NO20070137L (no) | Heterocykliske antivirale forbindelser | |
NO20063599L (no) | Ytterligere heterosykliske forbindelser og deres anvendelse som metabotrofiske glutamatreseptorantagonister | |
NO20055421L (no) | Kinolinderivater som fosfodiestrase-inhibitorer | |
NO20061363L (no) | Pyrazolo- og imidazo- pyrimidinderivater | |
NO20054085L (no) | Substituerte heksahydropyrazino [1,2-a]pyrimidin-4,7-dionderivater, fremgangsmater for fremstilling og anvendelse derav som medikamenter | |
NO20054726L (no) | 2, 4-di(fenylamino)pyrimidiner anvendelige ved behandling av neoplastiske sykdommer, inflammasjons- og immunsystemforstyrrelser | |
NO20074647L (no) | 3,4 dihydro-1H-isoquinolin-2-karboksylsyre-5-ammopyridin-2-yl estere | |
NO20055649L (no) | Substituert dihydrokinazolin med antiviale egenskaper | |
NO20090266L (no) | Piperazinylderivater anvendelige i behandlingen av GPR38 receptormedierte sykdommer | |
NO20065678L (no) | 3-(4-heteroarylcykloheksylamino) cyklopentankarboksamider som modulatorer for kjemokinreseptorer. | |
NO20083585L (no) | Hetero-bisykliske antivirale forbindelser |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |